Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    HER2 Expression in Urothelial Carcinoma (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Early Diagnosis Improvement of Chlamydia Infections
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Support for the Professions Senegal
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology China
    Improving cancer care in patients with metastatic breast cancer
    Release Date:
    Review Process: Pfizer Internal
    Translation:(link)
    Translation:(link)
    Quality Improvement Oncology Kazakhstan
    An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Inflammation & Immunology All
    Improving Health Equity in IBD through Disparities Research
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology All
    Emerging Science in the Management of Acute Myeloid Leukemia
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Addressing Systemic Drivers of Racial Health Inequities
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Health Equity USA
    Diversity in Postmarketing Drug Safety Surveillance
    Release Date:
    Review Process: Pfizer Internal
    Research Patient Safety USA
    Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient Education
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Ghana, Rwanda
    Increasing Awareness and Understanding of Duchenne Muscular Dystrophy in Latin America, Africa, Middle East and Asia-Pacific
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Improving Education Disparities of Young Gatroenterologists to Deliver Appropriate Medical Care to IBD Patients
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Argentina, Brazil, India, Malaysia, Mexico, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates
    2023 Inflammatory Bowel Disease (IBD) Fellowship – India
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology India